Spontaneous pneumothorax and spontaneous pneumomediastinum in COVID-19 patients.

Background: Spontaneous pneumothorax (SP) and or spontaneous pneumomediastinum (SM) are once in a while found clinical complication among the COVID-19 patients. Objectives: This study aims to investigate the occurrence of spontaneous pneumothorax and or spontaneous pneumomediastinum, risk factors,...

Full description

Bibliographic Details
Main Author: Mohamed Sabry Abdelmotaleb*
Format: Article
Language:English
Published: South Valley University, Faculty of Medicine 2022-07-01
Series:SVU - International Journal of Medical Sciences
Subjects:
Online Access:https://svuijm.journals.ekb.eg/article_236777.html
_version_ 1811254725943754752
author Mohamed Sabry Abdelmotaleb*
author_facet Mohamed Sabry Abdelmotaleb*
author_sort Mohamed Sabry Abdelmotaleb*
collection DOAJ
description Background: Spontaneous pneumothorax (SP) and or spontaneous pneumomediastinum (SM) are once in a while found clinical complication among the COVID-19 patients. Objectives: This study aims to investigate the occurrence of spontaneous pneumothorax and or spontaneous pneumomediastinum, risk factors, and outcomes among COVID-19 patients. Patients and methods: This is a retrospective chart review of all COVID-19 patients who complicated with a spontaneous pneumothorax and/or spontaneous pneumomediastinum with subcutaneous emphysema from April 2020 to December 2021. Results: A total 49 COVID-19 patients who complicated with a spontaneous pneumothorax and/or spontaneous pneumomediastinum with subcutaneous emphysema were included in the study. Incidence of a SP and/or SM with SC emphysema among ICU admitted COVID-19 patients was 8.03% (49/610) and was 0.98% (49/5000) among all hospitalized COVID-19 patients. The overall mean age was 53.31± 15.36 and most of them were males 33 (67.35%) patients. 31 (63.27%) patients had co-morbidities. We had 24(48.98%) patients with spontaneous pneumothorax without spontaneous pneumomediastinum and subcutaneous emphysema, 17(34.69%) patients had spontaneous pneumothorax with spontaneous pneumomediastinum and subcutaneous emphysema and 8(16.33%) patients had spontaneous pneumomediastinum and subcutaneous emphysema without, Spontaneouspneumothorax.11(22.45%) patients were managed conservatively while right Chest tube was inserted in 16(32.65%) patients, left chest tube was inserted in 9(18.37%) patients and bilateral chest tubes were inserted in 13(26.53%) patients. Total mortality was 33 (67.35%) patients Conclusions: Spontaneous pneumothorax is one of the complications of COVID-19 with a higher mortality rate and worse prognosis.
first_indexed 2024-04-12T17:12:59Z
format Article
id doaj.art-4b6d1c98accb4065a965bcad11cce27d
institution Directory Open Access Journal
issn 2735-427X
2636-3402
language English
last_indexed 2024-04-12T17:12:59Z
publishDate 2022-07-01
publisher South Valley University, Faculty of Medicine
record_format Article
series SVU - International Journal of Medical Sciences
spelling doaj.art-4b6d1c98accb4065a965bcad11cce27d2022-12-22T03:23:45ZengSouth Valley University, Faculty of MedicineSVU - International Journal of Medical Sciences2735-427X2636-34022022-07-0152253261https://dx.doi.org/10.21608/svuijm.2022.136679.1310Spontaneous pneumothorax and spontaneous pneumomediastinum in COVID-19 patients.Mohamed Sabry Abdelmotaleb*0Department of Cardiothoracic surgery, Faculty of Medicine, Menoufia University, Shebin Elkoum, Menoufia, EgyptBackground: Spontaneous pneumothorax (SP) and or spontaneous pneumomediastinum (SM) are once in a while found clinical complication among the COVID-19 patients. Objectives: This study aims to investigate the occurrence of spontaneous pneumothorax and or spontaneous pneumomediastinum, risk factors, and outcomes among COVID-19 patients. Patients and methods: This is a retrospective chart review of all COVID-19 patients who complicated with a spontaneous pneumothorax and/or spontaneous pneumomediastinum with subcutaneous emphysema from April 2020 to December 2021. Results: A total 49 COVID-19 patients who complicated with a spontaneous pneumothorax and/or spontaneous pneumomediastinum with subcutaneous emphysema were included in the study. Incidence of a SP and/or SM with SC emphysema among ICU admitted COVID-19 patients was 8.03% (49/610) and was 0.98% (49/5000) among all hospitalized COVID-19 patients. The overall mean age was 53.31± 15.36 and most of them were males 33 (67.35%) patients. 31 (63.27%) patients had co-morbidities. We had 24(48.98%) patients with spontaneous pneumothorax without spontaneous pneumomediastinum and subcutaneous emphysema, 17(34.69%) patients had spontaneous pneumothorax with spontaneous pneumomediastinum and subcutaneous emphysema and 8(16.33%) patients had spontaneous pneumomediastinum and subcutaneous emphysema without, Spontaneouspneumothorax.11(22.45%) patients were managed conservatively while right Chest tube was inserted in 16(32.65%) patients, left chest tube was inserted in 9(18.37%) patients and bilateral chest tubes were inserted in 13(26.53%) patients. Total mortality was 33 (67.35%) patients Conclusions: Spontaneous pneumothorax is one of the complications of COVID-19 with a higher mortality rate and worse prognosis.https://svuijm.journals.ekb.eg/article_236777.htmlcovid-19; emphysema; pneumomediastinum; pneumonia; pneumothorax
spellingShingle Mohamed Sabry Abdelmotaleb*
Spontaneous pneumothorax and spontaneous pneumomediastinum in COVID-19 patients.
SVU - International Journal of Medical Sciences
covid-19; emphysema; pneumomediastinum; pneumonia; pneumothorax
title Spontaneous pneumothorax and spontaneous pneumomediastinum in COVID-19 patients.
title_full Spontaneous pneumothorax and spontaneous pneumomediastinum in COVID-19 patients.
title_fullStr Spontaneous pneumothorax and spontaneous pneumomediastinum in COVID-19 patients.
title_full_unstemmed Spontaneous pneumothorax and spontaneous pneumomediastinum in COVID-19 patients.
title_short Spontaneous pneumothorax and spontaneous pneumomediastinum in COVID-19 patients.
title_sort spontaneous pneumothorax and spontaneous pneumomediastinum in covid 19 patients
topic covid-19; emphysema; pneumomediastinum; pneumonia; pneumothorax
url https://svuijm.journals.ekb.eg/article_236777.html
work_keys_str_mv AT mohamedsabryabdelmotaleb spontaneouspneumothoraxandspontaneouspneumomediastinumincovid19patients